Difference between revisions of "Part:BBa K3142006"
(2 intermediate revisions by the same user not shown) | |||
Line 3: | Line 3: | ||
<partinfo>BBa_K3142006 short</partinfo> | <partinfo>BBa_K3142006 short</partinfo> | ||
− | Food-derived antihypertensive peptide, which | + | Food-derived antihypertensive peptide, which is a highly active hypotensive peptide.The sequence has been optimized for ''lactic acid bacteria''. It is a small molecule bioactive peptide that is difficult to directly biosynthesize. Therefore, the fusion expression strategy is currently used. |
+ | |||
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
Line 16: | Line 17: | ||
<partinfo>BBa_K3142006 parameters</partinfo> | <partinfo>BBa_K3142006 parameters</partinfo> | ||
<!-- --> | <!-- --> | ||
+ | |||
+ | ===Reference=== | ||
+ | *Nakano, D., K. Ogura, M. Miyakoshi, F. Ishii, et, al. Antihypertensive effect of angiotensin I-converting enzyme inhibitory peptides from a sesame protein hydrolysate in spontaneously hypertensive rats. [J] Biosci Biotechnol Biochem 2006, 70:1118–1126. |
Latest revision as of 12:50, 21 October 2019
Milk-derived antihypertensive tripeptide(IPP)
Food-derived antihypertensive peptide, which is a highly active hypotensive peptide.The sequence has been optimized for lactic acid bacteria. It is a small molecule bioactive peptide that is difficult to directly biosynthesize. Therefore, the fusion expression strategy is currently used.
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Reference
- Nakano, D., K. Ogura, M. Miyakoshi, F. Ishii, et, al. Antihypertensive effect of angiotensin I-converting enzyme inhibitory peptides from a sesame protein hydrolysate in spontaneously hypertensive rats. [J] Biosci Biotechnol Biochem 2006, 70:1118–1126.